BREAKING
Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 57 minutes ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 3 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 5 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 7 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 8 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 8 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 9 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 11 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 11 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 12 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 57 minutes ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 3 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 5 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 7 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 8 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 8 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 9 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 11 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 11 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 12 hours ago
ADVERTISEMENT
AlphaGraphs

Crawford & Company (CRD-A, CRD-B) Earnings: 3Q23 Key Numbers

Crawford & Company (NYSE: CRD-A, CRD-B) reported revenues before reimbursements of $325.6 million for the third quarter of 2023, up 10% year-over-year. Net income attributable to shareholders was $12.3 million, or $0.25 per share, compared to a loss of $15.1 million, or $0.31 per share, last year. Adjusted EPS totaled $0.35 for CRD-A and $0.36 […]

November 6, 2023 1 min read

Crawford & Company (NYSE: CRD-A, CRD-B) reported revenues before reimbursements of $325.6 million for the third quarter of 2023, up 10% year-over-year.

Net income attributable to shareholders was $12.3 million, or $0.25 per share, compared to a loss of $15.1 million, or $0.31 per share, last year. Adjusted EPS totaled $0.35 for CRD-A and $0.36 for CRD-B.

Consolidated cash and cash equivalents as of September 30, 2023, totaled $49.2 million.

ADVERTISEMENT